 In addition, and in lieu of common shares, Axovant is offering to certain investors pre-funded warrants to purchase 3,301,998 common shares at a purchase price of 3.74999 per pre-funded warrant, which represents the per share public offering price for the common shares, minus the 0.00001 per share exercise price of each such pre-funded warrant. All of the common shares and pre-funded warrants are being offered by Axovant. 